BSE Live
Dec 05, 16:01Prev. Close
251.90
Open Price
252.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:48Prev. Close
252.25
Open Price
252.25
Bid Price (Qty.)
251.70 (500)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Indoco Remedies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | |
| 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||
| SHAREHOLDER'S FUNDS | ||||
| Equity Share Capital | 18.43 | 18.43 | 18.43 | |
| Total Share Capital | 18.43 | 18.43 | 18.43 | |
| Reserves and Surplus | 500.38 | 438.72 | 395.74 | |
| Total Reserves and Surplus | 500.38 | 438.72 | 395.74 | |
| Total Shareholders Funds | 518.81 | 457.15 | 414.17 | |
| Minority Interest | 0.00 | 0.25 | 0.20 | |
| NON-CURRENT LIABILITIES | ||||
| Long Term Borrowings | 12.85 | 13.79 | 27.39 | |
| Deferred Tax Liabilities [Net] | 27.07 | 30.54 | 34.81 | |
| Other Long Term Liabilities | 9.69 | 9.19 | 9.20 | |
| Long Term Provisions | 15.04 | 16.36 | 6.82 | |
| Total Non-Current Liabilities | 64.65 | 69.87 | 78.22 | |
| CURRENT LIABILITIES | ||||
| Short Term Borrowings | 75.38 | 57.96 | 64.84 | |
| Trade Payables | 119.86 | 70.66 | 68.26 | |
| Other Current Liabilities | 40.97 | 53.98 | 51.35 | |
| Short Term Provisions | 25.92 | 19.54 | 14.84 | |
| Total Current Liabilities | 262.12 | 202.15 | 199.28 | |
| Total Capital And Liabilities | 845.58 | 729.41 | 691.86 | |
| ASSETS | ||||
| NON-CURRENT ASSETS | ||||
| Tangible Assets | 296.08 | 296.13 | 291.00 | |
| Intangible Assets | 43.42 | 29.18 | 30.43 | |
| Capital Work-In-Progress | 26.03 | 24.36 | 21.99 | |
| Fixed Assets | 402.21 | 369.43 | 359.21 | |
| Non-Current Investments | 0.17 | 0.17 | 0.12 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 57.53 | 55.13 | 56.72 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 460.23 | 424.85 | 416.18 | |
| CURRENT ASSETS | ||||
| Current Investments | 0.00 | 0.00 | 0.00 | |
| Inventories | 149.12 | 110.22 | 93.18 | |
| Trade Receivables | 155.38 | 138.13 | 127.08 | |
| Cash And Cash Equivalents | 15.40 | 13.39 | 13.99 | |
| Short Term Loans And Advances | 65.04 | 42.48 | 41.39 | |
| OtherCurrentAssets | 0.41 | 0.35 | 0.04 | |
| Total Current Assets | 385.36 | 304.56 | 275.68 | |
| Total Assets | 845.58 | 729.41 | 691.86 | |
| OTHER ADDITIONAL INFORMATION | ||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||
| Contingent Liabilities | 19.10 | 27.93 | 30.28 | |
| BONUS DETAILS | ||||
| Bonus Equity Share Capital | 6.14 | 6.14 | 6.14 | |
| NON-CURRENT INVESTMENTS | ||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.17 | 0.17 | 0.12 | |
| CURRENT INVESTMENTS | ||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher